Skip to content

Effects of electroacupuncture in the treatment of chronic spontaneous urticaria (CSU) : a randomized controlled trial

Effects of electroacupuncture in the treatment of chronic spontaneous urticaria (CSU) : a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005016
Enrollment
Unknown
Registered
2021-07-05
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic spontaneous urticaria

Interventions

Sponsors

Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with chronic spontaneous urticaria with clinical diagnosis of traditional Chinese and Western medicine; 2. Aged between 18-65 years, no gender limit; 3. No serious heart, liver, lung, kidney and metabolic diseases; 4. Have not received corticosteroids, non-steroids, antihistamines, immunosuppressants and biological agents recently (within 1 month); 5. Disease duration > 6 weeks; 6. Those who voluntarily participate in this experiment, can obey the treatment plan, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who have infectious skin diseases, or who have infection, ulcers or scars on the skin of the treatment site; 2. Pregnancy and lactation patients; 3. Patients with malignant tumor, or spontaneous bleeding tendency such as thrombocytopenia and hemophilia; 4. Patients with serious primary diseases such as cerebrovascular, autoimmune diseases or hematopoietic system, mental patients or combined with secondary infection; 5. Patients with severe acute exacerbation of chronic urticaria, such as chest tightness, wheezing, dyspnea involving the laryngeal mucosa, and life-threatening suffocation due to laryngeal edema; those with systemic symptoms such as high fever, chills, and rapid pulse; 6. Those who are participating in other clinical trials or who have participated in other clinical trials within 12 weeks; 7. Patients who are not suitable for inclusion in the group according to the judgment of the doctor.

Design outcomes

Primary

MeasureTime frame
measles activity score;chronic urticaria quality of life questionnaire;

Secondary

MeasureTime frame
degree of itching;number of wheal episodes;urticaria control test, UCT;

Countries

China

Contacts

Public ContactLin Haibo

Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji'nan University

linhaibo666@qq.com+86 18675013166

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026